Knowledge sharing at CT-Cann 2023
February 20, 2023 | IN NEWS | BY MCCS
The Medical Cannabis Clinicians Society recently endorsed and participated in the 2nd International Congress on Clinical Trials on Cannabis (CT-Cann2023), an education and scientific conference aimed at clinicians and researchers working in the field of medical cannabis. This conference was an excellent opportunity to share our knowledge and expertise with others and learn from our peers about the latest developments and research in this rapidly-evolving field.
At MCCS, we are committed to providing education and support for clinicians on the safe and effective use of medical cannabis to improve patient outcomes. We believe that education and collaboration among healthcare professionals is critical to achieving this goal. That is why we were not only delighted to participate in this conference but also to endorse the event.
During the conference, we had the opportunity to hear from leading experts in the field of medical cannabis research, policy, and practice, including Dr David Finn, Dr Silviu Brill, Prof Dedi Meiri, Dr Staci Gruber and Dr Haggai Sharon.
During the conference, we were pleased to have several members of the MCCS expert committee speak and share their knowledge with the audience. Prof Mike Barnes opened the conference with an overview of the current UK status of medical cannabis in the UK and the challenges. We believe that this discussion was particularly valuable for clinicians developing their prescribing practice. Vice-Chair, Dr. Dani Gordon, presented on the research findings on cannabis and long COVID, which was a topic of great interest to many attendees. Dr. Gordon’s presentation highlighted the potential benefits of using medical cannabis to manage long-term symptoms of COVID-19. We also had the pleasure of hearing from Dr. Niraj Singh, who spoke about the MCCS, our vision and mission, and the practical support we provide to our members. Dr. Singh gave a helpful overview of the tools and resources that MCCS members have access to, such as our educational program, clinical guidelines, and peer support network. This presentation was particularly relevant for clinicians who are new to the field of medical cannabis, as it provided an overview of the support available to them as they navigate this complex and rapidly-evolving field.
We appreciated the opportunity to share our knowledge and expertise with other attendees and to learn from our peers. As the medical cannabis industry continues to develop, we believe that collaboration and education among healthcare professionals is more important than ever.
We are committed to continuing to endorse and participate in conference and other like it to have the opportunity to engage with other clinicians and researchers working in the field of medical cannabis. We believe that this type of event, which brings together a diverse group of healthcare professionals, is essential for fostering collaboration and knowledge sharing. As we move forward, we will keep working toward our goal of providing education and support for doctors who prescribe medical cannabis to improve patient outcomes.
New to medical cannabis prescribing?
We would like to invite clinicians who are interested in the field of medical cannabis to become members of the MCCS. As a member, you will have access to a wealth of educational resources and tools, as well as the opportunity to connect with other healthcare professionals working in this field. We are a supportive community of like-minded professionals, and we are committed to promoting safe and effective use of medical cannabis to improve patient outcomes.
To become a member of the MCCS, please join here. Our membership is open to all healthcare professionals, including doctors, nurses, pharmacists, and other allied healthcare professionals. We also offer student memberships for those who are currently studying healthcare professions.
We look forward to welcoming new members to the MCCS and working together to advance the field of medical cannabis education, research, policy, and practice.